only other treatment ..........The first treatment for Fabry's disease was approved by the US FDA on April 24, 2003. Fabrazyme (agalsidase beta) was licensed to the Genzyme Corporation. It is an enzyme replacement therapy (ERT) designed to provide the enzyme the patient is missing as a result of a genetic malfunction. The drug is expensive — in 2012, Fabrazyme's annual cost was about US$200,000 per patient,[ it wont take to many patients to make money
out with the dept of EDUCATION ? BUT we have a great wall of America. GET rid of the IRS and SEC and give hedge fund networks your SS. Right Better read Hilaries book.
BS______________ its just a little over its book value and average for the last few years. We are looking at one of the worst virus scares in a while. The future could bring un paralleled gains and business. We are just now up to where the stock should be with out the opportunity for a wind fall. Up 50% in a year from those lows is nothing.
You don't get royalties and work with Bristol and Monsanto for nothing . They are here just for a short while.
they have enough for Phase 1 testing. The rest could be produced in a few months.
you going to think you have EBOLA very soon. You will be sic.
I hope they try a few different drugs. Lets find out what works for future scares. This is a great way to beef up the virus arsenal.
exactly what we are saying. ONE of just a few........................ Turn the news on and educate you self about how bad it can get.
HELLO! over a hundred health care workers following safety guide lines have been affected. This could be bad and the world will need all the guns it has.,